Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.
Dorff T, Hirasawa Y, Acoba J, Pagano I, Tamura D, Pal S, Zhang M, Waitz R, Dhal A, Haynes W, Shon J, Scholz M, Furuya H, Chan OTM, Huang J, Rosser C.
Dorff T, et al. Among authors: pagano i.
J Immunother Cancer. 2021 Aug;9(8):e002931. doi: 10.1136/jitc-2021-002931.
J Immunother Cancer. 2021.
PMID: 34376554
Free PMC article.
Clinical Trial.